Soren T. Bonlokke

Arhus, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Impaired fibrinolysis and increased clot strength are potential risk factors for thrombosis in lymphoma.

Impaired fibrinolysis and increased clot strength are potential risk factors for thrombosis in lymphoma.

Journal: Blood advances

Published: August 04, 2023

The real-world use and efficacy of pomalidomide for relapsed and refractory multiple myeloma in the era of CD38 antibodies.

The real-world use and efficacy of pomalidomide for relapsed and refractory multiple myeloma in the era of CD38 antibodies.

Journal: EJHaem

Published: July 13, 2023

Prophylaxis with low dose tranexamic acid in acute myeloid leukemia patients undergoing intensive chemotherapy.

Prophylaxis with low dose tranexamic acid in acute myeloid leukemia patients undergoing intensive chemotherapy.

Journal: EJHaem

Published: April 11, 2023

Catheter-directed thrombolysis for massive deep vein thrombosis in an adolescent with severe antithrombin deficiency.

Catheter-directed thrombolysis for massive deep vein thrombosis in an adolescent with severe antithrombin deficiency.

Journal: Clinical case reports

Published: September 21, 2021

The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab-containing line of therapy.

The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab-containing line of therapy.

Journal: American journal of hematology

Published: September 10, 2021

Outcome of treatment with carfilzomib before and after treatment with daratumumab in relapsed or refractory multiple myeloma patients.

Outcome of treatment with carfilzomib before and after treatment with daratumumab in relapsed or refractory multiple myeloma patients.

Journal: Hematological oncology

Published: June 11, 2021

Altered Fibrinolysis in Hematological Malignances.

Altered Fibrinolysis in Hematological Malignances.

Journal: Seminars in thrombosis and hemostasis

Published: May 31, 2021

The real-world outcomes of multiple myeloma patients treated with daratumumab.

The real-world outcomes of multiple myeloma patients treated with daratumumab.

Journal: PloS one

Published: March 19, 2021

Targeted next generation sequencing panel for HPV genotyping in cervical cancer.

Targeted next generation sequencing panel for HPV genotyping in cervical cancer.

Journal: Experimental and molecular pathology

Published: August 20, 2020

Once- versus twice-daily aspirin treatment in patients with essential thrombocytosis.

Once- versus twice-daily aspirin treatment in patients with essential thrombocytosis.

Journal: Platelets

Published: February 15, 2018

Platelet characteristics in patients with essential thrombocytosis.

Platelet characteristics in patients with essential thrombocytosis.

Journal: Cytometry. Part B, Clinical cytometry

Published: January 30, 2018

Bronchoscopy in patients with haemoptysis and normal computed tomography of the chest is unlikely to result in significant findings.

Bronchoscopy in patients with haemoptysis and normal computed tomography of the chest is unlikely to result in significant findings.

Journal: Danish medical journal

Published: August 05, 2015

Showing 1-12 of 12

Last Updated: 09/26/2026